Search the Newsreel

Die Thermo-Fisher-Aktie reagiert auf starke Q2-Zahlen und angehobene Prognose

Thermo Fisher Scientific Completes Sale of its Microbiology Business to Astorg

WALTHAM, Mass., August 12, 2026--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it has completed the sale of its microbiology business to Astorg, a leading pan-European private equity firm, forconsideration of approximately $1.075 billion, consisting of …

Can A New Vitiligo Registry Move The Needle For Thermo Fisher (TMO)?

Thermo Fisher Scientific (NYSE:TMO) mostly sells the instruments and supplies that let other companies do science, not the treatments themselves. So when the company said on July 29 that it had launched the PPD CorEvitas Vitiligo Registry on July 14, to track how patients …

Thermo Fisher Scientific Collaborates with The Michael J. Fox Foundation to Advance Proteomics-Enabled Parkinson’s Precision Medicine

Olink™ Explore HT analysis of approximately 5,500 research samples completed, with data now available Key Facts Collaboration: Thermo Fisher Scientific and The Michael J. Fox Foundation expanded the Parkinson's Precision Medicine Initiative (PPMI) proteomic data resource. Scale: Approximately 5,500 research samples were analyzed using …

How Investors Are Reacting To Thermo Fisher Scientific (TMO) New FDA-Cleared Multiple Myeloma Platform

In late July 2026, Thermo Fisher Scientific used the ADLM conference in Anaheim to highlight new FDA-cleared diagnostic platforms, including the EXENT Solution for multiple myeloma and EliA CTD 13 Screen for systemic autoimmune connective tissue diseases, alongside expanded digital and quality-control offerings for …

Thermo Fisher (TMO) vs Danaher (DHR): Which Life Sciences Stock Looks Better Positioned?

Thermo Fisher Scientific Inc. (NYSE:TMO) and Danaher Corporation (NYSE:DHR) are two of the world's largest life sciences tools companies, making them natural competitors for investors looking to capitalize on a recovery in pharmaceutical and biotechnology research spending. Both companies delivered better-than-expected second-quarter results, but …

Thermo Fisher Scientific Inc (TMO) Aktuelle Aktien-News

Werden die neue EXENT-Myelom-Plattform von Thermo Fisher (TMO) und die Ergebnisse des zweiten Quartals die Einschätzung des Unternehmens im Diagnostikbereich verändern?

Thermo Fisher Stock Clawed Back From a 31% Slide. A Guidance Raise May Explain Why.

Unlocking Thermo Fisher (TMO) International Revenues: Trends, Surprises, and Prospects

Have you evaluated the performance of Thermo Fisher Scientific's (TMO) international operations during the quarter that concluded in June 2026? Considering the extensive worldwide presence of this maker of scientific instrument and laboratory supplies, analyzing the patterns in international revenues is crucial for understanding …

Analysts Appear Bullish on Thermo Fisher (TMO): Is The Stock Really a Buy After Earnings?

Thermo Fisher Scientific Inc. (NYSE:TMO) recently announced strong fiscal Q2 2026 results, with revenue growing 10% to $11.99 billion, GAAP diluted EPS rising 9% to $4.68, and adjusted EPS growing 13% to $6.03. The results prompted several analysts to raise their price targets, but …

Thermo Fisher Scientific (TMO) Could Be 2% Undervalued After Q2 Earnings Beat

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Thermo Fisher Scientific (TMO) is back in focus after reporting second quarter results that exceeded market expectations, supported by broad-based demand and fresh regulatory clearances …

The Top 5 Analyst Questions From Thermo Fisher’s Q2 Earnings Call

The Top 5 Analyst Questions From Thermo Fisher's Q2 Earnings Call Thermo Fisher's second quarter saw a notable uptick in end-market activity, propelling results above Wall Street's expectations and leading to a positive market reaction. Management pointed to stronger demand across pharmaceutical, biotech, industrial, …

Thermo Fisher Scientific Presents End-to-End Diagnostic and Lab Solutions Addressing Unmet Clinical Needs at ADLM 2026

Key facts: Thermo Fisher's specialty diagnostics portfolio addresses high-impact clinical needs across multiple myeloma monitoring with the EXENT® Solution, community oncology testing, critical care, allergy and autoimmune diagnostics, including connective tissue disease testing with the EliA™ CTD 13 Screen, maternal health, and molecular diagnostics. …

Warum Thermo Fisher Scientific (TMO) nach über den Erwartungen liegenden Ergebnissen im zweiten Quartal, dem Abschluss des Aktienrückkaufs und der Markteinführung von InstaFlux um 6,7 % gestiegen ist

Thermo Fisher Scientific's Strong Q2 Not Enough to 'Meaningfully' Change H2 Outlook, RBC Says

Thermo Fisher Scientific's (TMO) broad-based improvement in Q2 is not enough to "meaningfully" chang PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have a …

TMO Q2 Deep Dive: Broad-Based End Market Growth and Strategic Portfolio Moves

TMO Q2 Deep Dive: Broad-Based End Market Growth and Strategic Portfolio Moves Life sciences company Thermo Fisher (NYSE:TMO) reported Q2 CY2026 results topping the market's revenue expectations , with sales up 10.5% year on year to $11.99 billion. Its non-GAAP profit of $6.03 per …

Thermo Fisher raises 2026 outlook after 10% growth in Q2

Thermo Fisher Scientific has reported Q2 revenues of $11.99bn, equating to a year-over-year (YoY) growth margin of 10%, prompting the company to raise its 2026 outlook. Besting its Q2 2025 performance of $10.85bn, Thermo Fisher now expects profits for 2026 to fall in the …

Thermo Fisher Raised Full-Year Guidance After a Standout Q2 Earnings Call

Thermo Fisher (TMO) Climbs 8.7% on Solid Earnings, Price Target Upgrades

Thermo Fisher Scientific Inc. (NYSE:TMO) saw its share prices increase by 8.71 percent on Thursday to close at $572.32 apiece, as investors took heart from the strong earnings performance and a series of price target upgrades for its stock. In the second quarter of …

Why Is Thermo Fisher (TMO) Stock Rocketing Higher Today

Why Is Thermo Fisher (TMO) Stock Rocketing Higher Today What Happened? Shares of life sciences company Thermo Fisher (NYSE:TMO) jumped 9.7% in the afternoon session after the company reported strong second-quarter earnings that beat Wall Street's estimates for both profit and revenue. For the …

Here's What Key Metrics Tell Us About Thermo Fisher (TMO) Q2 Earnings

Thermo Fisher Scientific (TMO) reported $11.99 billion in revenue for the quarter ended June 2026, representing a year-over-year increase of 10.5%. EPS of $6.03 for the same period compares to $5.36 a year ago. The reported revenue represents a surprise of +2.67% over the …

Thermo Fisher Scientific (TMO) Surpasses Q2 Earnings and Revenue Estimates

Thermo Fisher Scientific (TMO) came out with quarterly earnings of $6.03 per share, beating the Zacks Consensus Estimate of $5.71 per share. This compares to earnings of $5.36 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents …

Thermo Fisher stock rises 3% on second quarter earnings beat

Investing.com--On Thursday, Thermo Fisher Scientific Inc. (NYSE: TMO) reported second quarter results that exceeded analyst expectations, as the company demonstrated strengthening customer activity across its end markets. The life sciences tools maker's shares went up 3.14% in pre-market trading following the release. The company …

Thermo Fisher’s (NYSE:TMO) Q2 CY2026 Sales Top Estimates

Thermo Fisher's (NYSE:TMO) Q2 CY2026 Sales Top Estimates Life sciences company Thermo Fisher (NYSE:TMO) announced better-than-expected revenue in Q2 CY2026, with sales up 10.5% year on year to $11.99 billion. Its non-GAAP profit of $6.03 per share was 5.6% above analysts' consensus estimates. Is …

Thermo Fisher Scientific Q2 Income Climbs

(RTTNews) - Thermo Fisher Scientific (TMO) released a profit for its second quarter that Increases, from last year The company's earnings totaled $1.736 billion, or $4.68 per share. This compares with $1.617 billion, or $4.28 per share, last year. Excluding items, Thermo Fisher Scientific …

Thermo Fisher Scientific Reports Second Quarter 2026 Results

Revenue Grew 10% Including 5% Organic Revenue Growth Grew GAAP Diluted EPS 9% and Adjusted EPS 13% Customer Activity Across Our End Markets Continued to Strengthen WALTHAM, Mass., July 23, 2026--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today …

Thermo Fisher Scientific Q2 2026 Earnings Preview

* Thermo Fisher Scientific (TMO [https://seekingalpha.com/symbol/TMO]) is scheduled to announce Q2 earnings results on Thursday, July 23rd, before market open. * The consensus EPS estimate is $5.71 [https://seekingalpha.com/symbol/TMO/earnings/estimates] (+6.5% Y/Y) and the consensus revenue estimate is $11.7B (+7.7% Y/Y). * Over the last 2 …

What Makes Thermo Fisher Scientific (TMO) an Attractive Long-Term Bet?

Dodge & Cox Fund, an investment management company, released its second-quarter 2026 investor letter for "Dodge and Cox Stock Fund". A copy of the letter can be downloaded here. Despite volatile oil prices and rising inflation, U.S. equities reached record highs in Q2 2026, …

Earnings To Watch: Thermo Fisher (TMO) Reports Q2 Results Tomorrow

Earnings To Watch: Thermo Fisher (TMO) Reports Q2 Results Tomorrow Life sciences company Thermo Fisher (NYSE:TMO) will be announcing earnings results this Thursday morning. Here's what you need to know. Thermo Fisher beat analysts' revenue expectations last quarter, reporting revenues of $11.01 billion, up …

How FBI Rapid DNA Approval Shapes Thermo Fisher Scientific’s (TMO) Long-Term Forensics Strategy

Thermo Fisher Scientific's board previously authorized a quarterly cash dividend of US$0.47 per share, paid on October 15, 2026, to shareholders of record on September 15, 2026. More recently, its Applied Biosystems RapidINTEL Plus Cartridge gained FBI approval for generating CODIS-searchable Rapid DNA crime …

Thermo Fisher (TMO) Stock May Be Undervalued As Guidance Rises

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Thermo Fisher Scientific stock has delivered a 32.0% gain over the past year, and the latest Discounted Cash Flow (DCF) intrinsic value estimate …

Exploring Analyst Estimates for Thermo Fisher (TMO) Q2 Earnings, Beyond Revenue and EPS

Analysts on Wall Street project that Thermo Fisher Scientific (TMO) will announce quarterly earnings of $5.71 per share in its forthcoming report, representing an increase of 6.5% year over year. Revenues are projected to reach $11.68 billion, increasing 7.6% from the same quarter last …